Mesoblast
Melbourne · Founded 2004
About Mesoblast
Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes, and kidney disease, orthopedic spine conditions, and cardiovascular disorders.
Company Facts
- Founded: 2004
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $577.3M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2025)
- Ticker: asx:MSB
- Website: mesoblast.com
- Phone: (212) 880-2060
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/mesoblast-89648 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.